Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BX Other blood glucose lowering drugs, excl. insulins
A10BX08 Mitiglinide
D01854 Mitiglinide calcium hydrate (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3969 Others
D01854 Mitiglinide calcium hydrate (JP18)
Drug groups [BR:br08330]
Antidiabetic agent
DG01508 Sulfonylurea receptor agonist
DG01735 Glinide
D01854 Mitiglinide calcium hydrate
DG02044 Hypoglycemic agent
DG01735 Glinide
D01854 Mitiglinide calcium hydrate
Metabolizing enzyme substrate
DG02924 UGT substrate
D01854 Mitiglinide calcium hydrate
Drug classes [BR:br08332]
Antidiabetic agent
DG01735 Glinide
D01854 Mitiglinide calcium hydrate
DG02044 Hypoglycemic agent
D01854 Mitiglinide calcium hydrate
Target-based classification of drugs [BR:br08310]
Transporters
ABC transporters
ABCC subfamily
ABCC8(SUR1)/KCNJ11(KIR6.2)
D01854 Mitiglinide calcium hydrate (JP18) <JP>
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Chemicals
D01854 Mitiglinide calcium hydrate
D01854 Mitiglinide calcium tablets
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D01854
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D01854
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D01854